Sales estimate for IPI
In the near term, analysts’ estimate for Intrepid Potash’s (IPI) sales doesn’t show a positive momentum. However, since sales for fertilizer companies (XLB) are seasonal, we take expectations for the next four quarters into consideration. For that time frame, sales are expected to remain almost flat.
Wall Street analysts are estimating total sales of $43.1 million, which is expected to decline 1.9% from $43.91 million in Q2 2017. For the next four quarters, total sales for Intrepid Potash are estimated at $161.5 million, which would be a decline of about 1% from $162.5 million in the last four quarters.
The weakness in sales doesn’t necessarily mean a weakness in the overall market, as is the case for commodities companies. In a bid to optimize operations, Intrepid Potash curtailed rationed capacity, which has already lowered its ability to ship more volumes.
Its peers Israel Chemicals (ICL) is estimated to report 4% growth in year-over-year sales. Mosaic (MOS) is estimated to report year-over-year sales of 21% over the next four quarters. However, these two companies also produce and distribute phosphate fertilizers, unlike Intrepid Potash that has a large exposure to potash fertilizers.
Next, let’s take a look at Intrepid Potash’s margins expectations.